Cart
sales@molnova.com
Retagliptin Phosphate
CAS No. 1256756-88-3
Retagliptin Phosphate( SP 2086 )
Catalog No. M23428 CAS No. 1256756-88-3
Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 67 | In Stock |
|
| 5MG | 110 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 332 | In Stock |
|
| 50MG | 502 | In Stock |
|
| 100MG | 709 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
| 1 mL x 10 mM in DMSO | 72 | In Stock |
|
| 2MG | 35 | In Stock |
|
| 5MG | 55 | In Stock |
|
| 10MG | 89 | In Stock |
|
| 25MG | 164 | In Stock |
|
| 50MG | 254 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRetagliptin Phosphate
-
NoteResearch use only, not for human use.
-
Brief DescriptionRetagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
-
DescriptionRetagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
-
In VitroRetagliptin is a class of compound used for research of type 2 diabetes. Retagliptin inhibits the degradation of GLP-1, thus amplifying the incretin effect.
-
In Vivo——
-
SynonymsSP 2086
-
PathwayMetabolic Enzyme/Protease
-
TargetDPP
-
RecptorDPP-4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1256756-88-3
-
Formula Weight562.36
-
Molecular FormulaC19H21F6N4O7P
-
Purity>98% (HPLC)
-
SolubilityDMSO: 150 mg/mL (266.73 mM)
-
SMILESCOC(C1=NC([N]2=C1CN(C(C[C@@H](CC3=C(F)C=C(F)C(F)=C3)N)=O)CC2)C(F)(F)F)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hu C, et al. Pharmacokinetics of Phosphate Retagliptin Tabletin in Patients with Renal Dysfunction. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Jan;49(1):74-80.
molnova catalog
related products
-
P32/98 hemifumarate
P32/98 hemifumarate is a dipeptidyl peptidase IV (DPP4) inhibitor with hypoglycemic properties that improves insulin sensitivity and β-cell responsiveness in the Zucker diabetic rat model, and may be useful in studies of type 2 diabetes and colitis.
-
TAK-100
TAK-100 is a potent, selective and orally active inhibitor of DPP-4 with IC50 of 5.3 nM.
-
AZD-7986
AZD-7986(INS-1007, AZD7986) is a highly potent, reversible, and selective DPP1 inhibitor with enzyme and cell pIC50 of 8.4.
